| # | Drug | Count |
|---|---|---|
| 0 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 4 |
| 1 | ESOMEPRAZOLE MAGNESIUM | 4 |
| 2 | MONTELUKAST SODIUM | 4 |
| 3 | ONABOTULINUMTOXINA | 4 |
| 4 | PREDNISONE | 4 |
| 5 | VALPROIC ACID | 4 |
| 6 | CETIRIZINE | 3 |
| 7 | IRON | 3 |
| 8 | METFORMIN | 3 |
| 9 | METFORMIN ER 500 MG | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLUTATHIONE | 1 | 0.0006 |
| 1 | FELBAMATE | 1 | 0.0006 |
| 2 | RILUZOLE | 1 | 0.0004 |
| 3 | IDURSULFASE | 1 | 0.0003 |
| 4 | PHENYTOIN | 3 | 0.0001 |
| 5 | VALPROIC ACID | 4 | 0.0001 |
| 6 | BRINZOLAMIDE | 1 | 0.0001 |
| 7 | CETIRIZINE HCL | 1 | 0.0001 |
| 8 | HYOSCYAMINE SULFATE | 1 | 0.0001 |
| 9 | TIOTROPIUM BROMIDE INHALATION SPRAY | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-epileptic Agent [EPC] | 5 |
| 1 | Corticosteroid [EPC] | 5 |
| 2 | Acetylcholine Release Inhibitor [EPC] | 4 |
| 3 | Mood Stabilizer [EPC] | 4 |
| 4 | Neuromuscular Blocker [EPC] | 4 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| 6 | Proton Pump Inhibitor [EPC] | 3 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 2 |
| 8 | Expectorant [EPC] | 2 |
| 9 | Insulin Analog [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Benzothiazole [EPC] | 1 | 0.0004 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Anticholinergic [EPC] | 1 | 0.0001 |
| 3 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Acetylcholine Release Inhibitor [EPC] | 4 | 0.0000 |
| 5 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 6 | Anti-epileptic Agent [EPC] | 5 | 0.0000 |
| 7 | Mood Stabilizer [EPC] | 4 | 0.0000 |
| 8 | Prostacycline Vasodilator [EPC] | 2 | 0.0000 |
| 9 | Dietary Cholesterol Absorption Inhibitor [EPC] | 1 | 0.0000 |